International law firm Addleshaw Goddard has advised Aleos Capital on the launch of its first investment vehicle, Aleos Fund I, which is targeting a fund size between €150 million and €200 million.

Aleos Fund I is structured to invest in high-growth companies within the life sciences sector, with a particular emphasis on opportunities related to health and wellness, sustainable nutrition, climate, and the environment. The fund will initially focus on investments in Spain and Portugal, with scope to expand into Southern Europe and Latin America.

Aleos Capital, a newly established Spanish asset management firm, is led by a team of seasoned professionals with extensive experience in private equity and the healthcare industry.

The Addleshaw Goddard team advising Aleos Capital was led by Funds Partner Isabel Rodríguez, supported by Senior Associate Enrique Torné and Associate Nemesio Fernández.